In accordance with ACR tips, allopurinol is strongly recommended as a primary-line urate-reducing medication. Genetic screening is suggested (for the variant known as HLA B*5801) just before starting up allopurinol since the carriers of this gene are at an elevated hazard of the serious allergic res